Skip to main content

Table 2 Dietary intakes of participants, obtained from six dietary records, at baseline and end of the intervention

From: The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial

Variable

Alpha-linolenic plus L-carnitine (N = 40)

Placebo (N = 40)

P a

Energy (kcal/day)

1966.25 ± 299.08

2023.10 ± 471.68

0.522

Carbohydrate (g/day)

315.15 ± 21.19

308.90 ± 18.07

0.160

Protein (g/day)

75.85 ± 9.83

76.77 ± 15.16

0.747

Fat (g/day)

72.77 ± 7.61

70.87 ± 7.99

0.280

PUFAs (g/day)

17.85 ± 4.88

16.28 ± 2.14

0.067

MUFA (g/day)

13.73 ± 2.72

12.71 ± 1.84

0.052

Fiber (g/d)

12.46 ± 2.53

13.56 ± 2.73

0.066

Folate (μg/d)

419.90 ± 45.74

415.39 ± 32.95

0.614

Vitamin C (mg/day)

104.35 ± 19.42

101.50 ± 15.01

0.465

Vitamin E (mg/day)

5.05 ± 0.62

4.84 ± 0.62

0.135

Zinc (mg/day)

8.94 ± 1.35

8.72 ± 1.09

0.414

Sodium (mg/d)

2434.95 ± 418.89

2290.37 ± 362.27

0.103

Potassium (mg/d)

2093.25 ± 201.65

2042.50 ± 187.52

0.247

Calcium (mg/d)

812.40 ± 92.31

840.80 ± 92.70

0.174

Magnesium (mg/day)

226.72 ± 24.59

219.12 ± 14.07

0.095

  1. Variables are expressed as mean ± SD
  2. Abbreviations: PUFAs Polyunsaturated fatty acids, MUFAs Monounsaturated fatty acids
  3. a Obtained from independent samples t-test